PPD：2023年罕见病行业调研报告-深度洞察行业外包需求（英文版）

The study was designed to be global but with a strong bias toward North America-based respondents, who comprise 70% of the audience; 20% of the audience are from Europe, while the remaining 10% are in the Asia Pacific region. The bulk of the audience (72%) works at a biopharmaceutical company, while 18% are employed by a small molecule pharmaceutical company; the remaining 10% are at R&D laboratories (6%) or academic institutions/universities (4%). 91% of the audience noted that they have